NCT04048343 Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma Status COMPLETED Phase PHASE3
NCT04046549 A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant Status COMPLETED Phase PHASE2
NCT04044560 Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant Status TERMINATED Phase PHASE2
NCT04040894 Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease Status APPROVED_FOR_MARKETING Phase N/A
NCT04034173 Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation Status NOT_YET_RECRUITING Phase PHASE2
NCT04031027 A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice Status COMPLETED Phase N/A
NCT03994731 Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout Status COMPLETED Phase PHASE4
NCT03989544 A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT03982992 Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab Status WITHDRAWN Phase PHASE2
NCT03974360 Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache Status COMPLETED Phase PHASE2
NCT03971071 A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache Status COMPLETED Phase PHASE4
NCT03969329 A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis Status RECRUITING Phase PHASE3
NCT03951220 The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss Status COMPLETED Phase N/A
NCT03944577 Impact of Evolocumab in Cardiac Transplant Patients With CAV Status COMPLETED Phase PHASE2
NCT03937154 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3